Literature DB >> 29695469

More Than Meets the Eye: Cerebrovascular Disease in Sickle Cell Disease Is About More Than Sickling.

Sneha Jacob1, Amelia Adcock2, Ann Murray2, Joanna Kolodney3.   

Abstract

Entities:  

Keywords:  anemia, sickle cell; cognitive dysfunction; hemoglobinopathies; magnetic resonance imaging; stroke

Mesh：

Year:  2018        PMID： 29695469      PMCID： PMC6419093          DOI： 10.1161/STROKEAHA.118.021057

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  10 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke.

Authors:  Robert J Adams; Margueritte Cox; Shelly D Ozark; Julie Kanter; Phillip J Schulte; Ying Xian; Gregg C Fonarow; Eric E Smith; Lee H Schwamm
Journal:  Stroke       Date:  2017-02-09       Impact factor: 7.914

3.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

4.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Transcranial Doppler ultrasonography in adults with sickle cell disease.

Authors:  N Valadi; G S Silva; L S Bowman; D Ramsingh; P Vicari; A C Filho; A R Massaro; A Kutlar; F T Nichols; R J Adams
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

Review 6.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future.

Authors:  Jeffrey A Switzer; David C Hess; Fenwick T Nichols; Robert J Adams
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

7.  Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

Authors:  Margaret T Lee; Sergio Piomelli; Suzanne Granger; Scott T Miller; Shannon Harkness; Donald J Brambilla; Robert J Adams
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 8.  Big strokes in small persons.

Authors:  Robert J Adams
Journal:  Arch Neurol       Date:  2007-11

9.  Molecular and cellular pathogenesis of hemoglobin SC disease.

Authors:  H F Bunn; C T Noguchi; J Hofrichter; G P Schechter; A N Schechter; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

Review 10.  The paradox of hemoglobin SC disease.

Authors:  Ronald L Nagel; Mary E Fabry; Martin H Steinberg
Journal:  Blood Rev       Date:  2003-09       Impact factor: 8.250
  10 in total
  2 in total

1.  Stroke in sickle cell disease in association with bilateral absence of the internal carotid arteries. Case report.

Authors:  Ivana Markovic; Zoran Milenkovic; Bosanka Jocic-Jakubi; Amna Al Futaisi; Kakaria Anupam Kakaria; Yasser Walli
Journal:  BMC Neurol       Date:  2022-05-17       Impact factor: 2.903

2.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.